AprilBio Co.,Ltd. (KOSDAQ:397030)

Market Cap	408.33B
Revenue	n/a
Net Income	n/a
Shares Out	22.44M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	222,459
Average Volume	434,014
Open	17,970
Previous Close	17,970
Day's Range	17,930 - 18,400
52-Week Range	12,460 - 25,900
Beta	1.57
RSI	61.73
Earnings Date	n/a

About AprilBio

AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics. The company develops products based on its long-acting protein medicine platform technology. It is developing various products for use in the treatment of rare diseases, cancer, male infertility, autoimmune and inflammatory diseases. The company was founded in 2013 and is headquartered in Chuncheon-si, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2013
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 397030